Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lucia Trudu

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Case Reports in Oncology|October 15, 2019
Unexpected Response to Nivolumab in a "Fast Progressor" Head and Neck Cancer PatientMartina Napolitano, Lucia Trudu, Federica Bertolini
Critical Reviews in Oncology/Hematology|November 19, 2019
Immunotherapy in head and neck cancer: The great challenge of patient selectionMartina Napolitano, Francesca Matilde Schipilliti, Lucia Trudu, et al.
Cancer Reports (Hoboken, N.J.)|January 15, 2025
Neratinib and the Role of Anti-HER2 Therapy in Salivary Duct CarcinomaMartina Napolitano, Lucia Trudu, Enrica Martinelli, et al.
Clinical Breast Cancer|March 5, 2022
Ocular Toxicity in Breast Cancer Management: Manual for The OncologistFabio Canino, Claudia Omarini, Krisida Cerma, et al.
International Journal of Molecular Sciences|December 10, 2021
Deepening the Knowledge of <i>ROS1</i> Rearrangements in Non-Small Cell Lung Cancer: Diagnosis, Treatment, Resistance and Concomitant AlterationsGiorgia Guaitoli, Federica Bertolini, Stefania Bettelli, et al.
Immunotherapy|April 13, 2022
Thyroid function impairment after chemo-immunotherapy for advanced NSCLC: a single institutional retrospective reportLucia Trudu, Giorgia Guaitoli, Federica Bertolini, et al.
Oral Diseases|October 14, 2020
Second primary tumors in head and neck cancer patients: The importance of a "tailored" surveillanceFederica Bertolini, Lucia Trudu, Federico Banchelli, et al.
Anti-Cancer Drugs|July 15, 2024
Complete and durable regression of leptomeningeal involvement during lorlatinib treatment in a patient with lung cancerGiorgia Guaitoli, Enrica Martinelli, Lucia Trudu, et al.
Human Gene Therapy|August 29, 2025
Genetic Engineering in CAR T Cells for Solid Tumors: Current State, Barriers and Future DevelopmentsRodrigo A Redondo-Frutos, Pedro Justicia-Lirio, Carmen Barbero-Jimenez, et al.
International Journal of Molecular Sciences|November 11, 2022
Dissecting Immunotherapy Strategies for Small Cell Lung Cancer: Antibodies, Ionizing Radiation and CAR-TGiorgia Guaitoli, Giovanni Neri, Eleonora Cabitza, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Case Reports in Oncology|October 15, 2019
Unexpected Response to Nivolumab in a "Fast Progressor" Head and Neck Cancer PatientMartina Napolitano, Lucia Trudu, Federica Bertolini
Critical Reviews in Oncology/Hematology|November 19, 2019
Immunotherapy in head and neck cancer: The great challenge of patient selectionMartina Napolitano, Francesca Matilde Schipilliti, Lucia Trudu, et al.
Cancer Reports (Hoboken, N.J.)|January 15, 2025
Neratinib and the Role of Anti-HER2 Therapy in Salivary Duct CarcinomaMartina Napolitano, Lucia Trudu, Enrica Martinelli, et al.
Clinical Breast Cancer|March 5, 2022
Ocular Toxicity in Breast Cancer Management: Manual for The OncologistFabio Canino, Claudia Omarini, Krisida Cerma, et al.
International Journal of Molecular Sciences|December 10, 2021
Deepening the Knowledge of <i>ROS1</i> Rearrangements in Non-Small Cell Lung Cancer: Diagnosis, Treatment, Resistance and Concomitant AlterationsGiorgia Guaitoli, Federica Bertolini, Stefania Bettelli, et al.
Immunotherapy|April 13, 2022
Thyroid function impairment after chemo-immunotherapy for advanced NSCLC: a single institutional retrospective reportLucia Trudu, Giorgia Guaitoli, Federica Bertolini, et al.
Oral Diseases|October 14, 2020
Second primary tumors in head and neck cancer patients: The importance of a "tailored" surveillanceFederica Bertolini, Lucia Trudu, Federico Banchelli, et al.
Anti-Cancer Drugs|July 15, 2024
Complete and durable regression of leptomeningeal involvement during lorlatinib treatment in a patient with lung cancerGiorgia Guaitoli, Enrica Martinelli, Lucia Trudu, et al.
Human Gene Therapy|August 29, 2025
Genetic Engineering in CAR T Cells for Solid Tumors: Current State, Barriers and Future DevelopmentsRodrigo A Redondo-Frutos, Pedro Justicia-Lirio, Carmen Barbero-Jimenez, et al.
International Journal of Molecular Sciences|November 11, 2022
Dissecting Immunotherapy Strategies for Small Cell Lung Cancer: Antibodies, Ionizing Radiation and CAR-TGiorgia Guaitoli, Giovanni Neri, Eleonora Cabitza, et al.
Pageof 2